Milestone
Dec 2024
Neonatal Clinical Trial Enrollment Complete
DP
Dec 31, 2024
Completed Enrollment of Neonatal Opioid Withdrawal Syndrome clinical study. Targeting Q2 submission to FDA.
Completed Enrollment of Neonatal Opioid Withdrawal Syndrome clinical study. Targeting Q2 submission to FDA.